In contrast, our 58 IDH-mutant astrocytomas were obtained from a larger cohort of 119 histological grade 2–3 gliomas [24], and we have solely assessed this genotype, rather than just correcting for genotype. This evidence concerns the gene IDH2 and central nervous system cancer.